Method for screening of 5HT7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
申请人:Laboratorios Del. Dr. Esteve, S.A.
公开号:EP2151777A1
公开(公告)日:2010-02-10
The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor; to a method for identifying them as 5-HT7 ligands, especially as agonists, by using a pharmacophore and a descriptor's profile filter; to pharmaceutical compositions comprising them; and to their use in therapy, in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
本发明涉及对5-HT7受体具有药理活性的化合物;涉及通过使用药效谱和描述符特征过滤器将它们鉴定为5-HT7配体,特别是激动剂的方法;涉及包含它们的药物组合物;涉及它们在治疗中的用途,特别是用于治疗和预防5-HT7参与的疾病,如中枢神经系统疾病。